Effects of morphine glucuronides on the function of opioid receptors in human SK-N-SH cells.
Morphine-3-glucuronide (M3G) and morphine-6-glucuronide (M6G) are active metabolites of morphine. The effects of M3G and M6G on the opioid receptor transduction system has not yet been fully elucidated. Formation of cAMP after treatment with various doses of morphine, M3G, and M6G was studied. M6G and morphine, but not M3G, showed a dose dependent inhibition of cAMP accumulation. Naloxone blocked the inhibitory effect of M6G, M3G, and morphine. Pretreatment with M3G did not change the effects of morphine and M6G. The G-protein inhibitor PTX, prevented morphine, M3G, and M6G effects on cAMP. M3G and M6G vary in their ability to interact with the opioid receptor effector system. Inhibition of cAMP evoked by activation of opioid receptors and inhibitory G-proteins may play a role in the actions of M6G and M3G.
Baker
L
L
Department of Pharmaceutical Sciences, College of Pharmacy, Idaho State University, Box 8334, Pocatello, ID, USA.
Dye
A
A
Ratka
A
A
D000527:Alprostadil / Q000494:pharmacology; D000242:Cyclic AMP / Q000378:metabolism; D004305:Dose-Response Relationship, Drug; D006801:Humans; D009022:Morphine Derivatives / Q000494:pharmacology*; D009270:Naloxone / Q000494:pharmacology; D011957:Receptors, Opioid / Q000187:drug effects* / Q000502:physiology; D014407:Tumor Cells, Cultured; D010566:Virulence Factors, Bordetella / Q000494:pharmacology
D009022:Morphine Derivatives; D011957:Receptors, Opioid; D010566:Virulence Factors, Bordetella; D009270:Naloxone; C035349:morphine-6-glucuronide; D000242:Cyclic AMP; D000527:Alprostadil; C018108:morphine-3-glucuronide